U.K. stomach cancer Dx startup hopes to raise $150K

07/15/2013 | Clinica (subscription required)

U.K.-based Oxford Micro Medical seeks to obtain $150,000 in outside capital, which it will use to further develop its NanoBreath device. The handheld device, which will integrate a mass spectrometry tool originally tailored for space exploration, is intended to offer a more cost-effective alternative to existing breath assays for detecting stomach cancer.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX